Table 5. Indications for ET in children and adolescents with congenital heart disease.
| Indication | Class of recommendation | Level of evidence |
|---|---|---|
| Assessment of cardiorespiratory fitness and risk stratification/prognosis in acyanotic CHD, before and after corrective surgery. 7 , 10 , 86 , 87 | IIa | B |
| Assessment of cardiorespiratory fitness and risk stratification/prognosis in cyanotic CHD, after corrective surgery. 7 , 86 , 87 | IIa | B |
| Assessment of arrhythmia behavior and risk stratification. 82 , 83 , 88 | IIa | B |
| Prescription and optimization of an exercise program, including a cardiovascular rehabilitation program. 89 , 90 | IIa | B |
| Assessment of cardiorespiratory fitness and risk stratification/prognosis after Fontan procedure. 84 , 91 , 92 | IIa | B |
| In compensated HF after interventional treatment, to optimization of therapy, risk stratification/prognosis, and clearance/prescription of cardiopulmonary rehabilitation. 93 , 94 | IIa | B |
| Assessment of symptoms triggered or worsened by exertion. 95 , 96 | IIa | C |
| In asymptomatic patients after tetralogy of Fallot repair, to assess the possibility of pulmonary valve replacement. 97 , 98 | IIb | B |
| Risk stratification/prognosis after tetralogy of Fallot repair. 99 , 100 | IIb | B |
| Assessment of cardiorespiratory fitness and risk stratification/prognosis after correction of transposition of the great arteries. 101 , 102 | IIb | B |
| Assessment of cardiorespiratory fitness in Fabry disease. 103 , 104 | IIb | B |
| Assessment of the degree of desaturation with exertion in clinically stable cyanotic CHD. * 7 | IIb | B |
| CHD with decompensated HF. | III | C |
| Decompensated cyanotic CHD. | III | C |
CHD: congenital heart disease; HF: heart failure.
*
Additional non-invasive oximetry monitoring performed additionally/concomitantly with the ET is advised.